Live Updates from the FDA Psychopharmacologic Advisory Committee Meeting on MDMA for PTSD
HCPLive
JUNE 4, 2024
Follow HCPLive's coverage of the full-day FDA committee meeting regarding Lykos Therapeutics' application for MDMA-assisted therapy as a novel treatment for patients with PTSD.
Let's personalize your content